» Articles » PMID: 1728732

Angioscopic Evaluation of Coronary-artery Thrombi in Acute Coronary Syndromes

Overview
Journal N Engl J Med
Specialty General Medicine
Date 1992 Jan 30
PMID 1728732
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Disruption of an atherosclerotic plaque in a coronary artery followed by the formation of a thrombus is believed to be the cause of both unstable angina and acute myocardial infarction. Although thrombolytic therapy is efficacious in patients with acute myocardial infarction, for unknown reasons it is far less effective in patients with unstable angina. We postulated that there might be differences in the composition of the coronary-artery thrombi in unstable angina and acute myocardial infarction.

Methods: To investigate the appearance of coronary-artery thrombi, we performed percutaneous transluminal coronary angioscopy in 15 patients with unstable angina and 16 with acute myocardial infarction. Angioscopy was performed within 48 hours after an episode of pain at rest in the patients with unstable angina and within 8 hours of onset in those with acute myocardial infarction.

Results: Angioscopy revealed coronary thrombi in all but two patients (one in each group). Of the 29 patients with thrombi, those with unstable angina were frequently observed to have grayish-white thrombi (10 of 14, 71 percent), but none were seen in the 15 patients with acute myocardial infarction (P less than 0.01). By contrast, reddish thrombi were observed in all 15 patients with acute myocardial infarction who had thrombi, but in only 4 of the 14 patients with unstable angina and thrombi (P less than 0.01). As assessed by coronary angiography, occlusive thrombi occurred frequently in patients with acute myocardial infarction (13 of 16 patients) but were not seen in any of the 15 patients with unstable angina (P less than 0.01).

Conclusions: Coronary-artery thrombi play an important part in the pathogenesis of unstable angina and acute myocardial infarction. However, the appearance of the thrombi is different in the two conditions, possibly reflecting differences in the composition of age of the thrombi or the presence or absence of blood flow in the artery. This difference may account for the contrasting results of thrombolytic therapy.

Citing Articles

Thromboinflammation is associated with clinical outcome after ST-elevation myocardial infarction.

Benkhoff M, Alde K, Ehreiser V, Dahlmanns J, Metzen D, Haurand J Blood Adv. 2024; 8(21):5581-5589.

PMID: 39226457 PMC: 11541696. DOI: 10.1182/bloodadvances.2024014273.


Myocardial perfusion scintigraphy in myocardial infarction - impact of ST-segment elevation and of Diabetes mellitus.

Barbosa J, Ferreira L, Pinto R, Barbosa E, Pereira J, Nunes J Porto Biomed J. 2024; 7(2):e167.

PMID: 38304157 PMC: 10830075. DOI: 10.1097/j.pbj.0000000000000167.


Chemokines, molecular drivers of thromboinflammation and immunothrombosis.

Leberzammer J, von Hundelshausen P Front Immunol. 2023; 14:1276353.

PMID: 37954596 PMC: 10637585. DOI: 10.3389/fimmu.2023.1276353.


Feasibility and safety of non-occlusive coronary angioscopic observation using a 4 Fr guiding catheter.

Matsushita M, Takano M, Munakata R, Sawatani T, Kurihara O, Komiyama H AsiaIntervention. 2022; 4(2):110-116.

PMID: 36483993 PMC: 9706746. DOI: 10.4244/AIJ-D-18-00003.


Cardiovascular events and atherosclerosis in patients with type 2 diabetes and impaired glucose tolerance: What are the medical treatments to prevent cardiovascular events in such patients?.

Ishii H J Diabetes Investig. 2022; 13(7):1114-1121.

PMID: 35377559 PMC: 9248425. DOI: 10.1111/jdi.13799.